The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease
Dan-Ying Zhang,1,* Lin Zhu,2,* Hai-Ning Liu,1,* Yu-Jen Tseng,3 Shu-Qiang Weng,1 Tao-Tao Liu,1 Ling Dong,1 Xi-Zhong Shen1,41Department of Gastroenterology, Zhongshan Hospital of Fudan University, Shanghai 200032, People’s Republic of China; 2Department of Geriatrics, Zhongshan Hospital of F...
Saved in:
Main Authors: | Zhang DY (Author), Zhu L (Author), Liu HN (Author), Tseng YJ (Author), Weng SQ (Author), Liu TT (Author), Dong L (Author), Shen XZ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
by: Chuangzhen Lin, et al.
Published: (2022) -
Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
by: Xiangbing Shu, et al.
Published: (2021) -
Non-alcoholic fatty liver and the gut microbiota
by: Stavros Bashiardes, et al.
Published: (2016) -
Fatty liver diseases, bile acids, and FXR
by: Yan Zhu, et al.
Published: (2016) -
Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver-Gut Axis
by: Linlin Liu, et al.
Published: (2020)